4//SEC Filing
Waisbourd Ram 4
Accession 0000899243-22-004607
CIK 0001785173other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:30 PM ET
Size
13.1 KB
Accession
0000899243-22-004607
Insider Transaction Report
Form 4
89bio, Inc.ETNB
Waisbourd Ram
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-02-01$1.93/sh+3,000$5,790→ 7,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-02-01−3,000→ 3,106 totalExercise: $1.93Exp: 2029-10-01→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2022-02-01$1.93/sh+4,000$7,720→ 4,000 total - Sale
Common Stock
2022-02-01$5.70/sh−7,000$39,900→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-02-01−4,000→ 14,203 totalExercise: $1.93Exp: 2028-11-09→ Common Stock (4,000 underlying)
Footnotes (3)
- [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $5.43 to $5.97. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This option represents a right to purchase a total of 102,203 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years.
- [F3]This option represents a right to purchase a total of 20,106 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years.
Documents
Issuer
89bio, Inc.
CIK 0001785173
Entity typeother
Related Parties
1- filerCIK 0001792064
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:30 PM ET
- Size
- 13.1 KB